Showing 2141-2150 of 3223 results for "".
- Alcon Celebrates World Sight Day, Strengthens Commitment to Enhancing Global Access to Eye Carehttps://modernod.com/news/alcon-celebrates-world-sight-day-strengthens-commitment-to-enhancing-global-access-to-eye-care/2476983/Thousands of Alcon associates worldwide are participating in activities to support the advancement of eye health in honor of World Sight Day. To celebrate the occasion, the company announced a theme for the upcoming year, “Alcon: The Official Sponsor of 20/20,” which is designed to highlight its
- On World Sight Day, Allergan Launches National Campaign to Raise Awareness of Glaucomahttps://modernod.com/news/on-world-sight-day-allergan-launches-national-campaign-to-raise-awareness-of-glaucoma/2476984/Allergan announced a national education campaign called “My Glaucoma.” The campaign is designed to help people understand the burden of living with glaucoma and empower those with the disease and their caregivers to feel comfortable speaking with their doctor about a treatment
- Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and New IOL Data at AAOhttps://modernod.com/news/alcon-to-highlight-acrysof-iq-panoptix-trifocal-iol-launch-and-groundbreaking-iol-data-at-aao/2476961/Alcon announced its plans to lead a wide range of informational and peer-to-peer educational programs at the American Academy of Ophthalmology (AAO) annual meeting on October 12-15 in San Francisco. The newly launched AcrySof IQ PanOptix Trifocal IOL, along with findings from the AAO IRIS (Intell
- Allegro to Present Clinical Research on the Novel Integrin-Regulating Portfolio at AAOhttps://modernod.com/news/allegro-to-present-clinical-research-on-the-novel-integrin-regulating-portfolio-at-aao/2476956/Allegro Ophthalmics announced that the results of its phase 2 clinical study of risuteganib (Luminate) for the treatment of intermediate nonexudative age-related macular degeneration (AMD) will be presented during AAO
- Allergan Expands Refresh Portfolio With New Refresh Relieva Lubricant Eye Drop Product Linehttps://modernod.com/news/allergan-expands-refresh-portfolio-with-new-refresh-relieva-lubricant-eye-drop-product-line/2476943/Allergan announced the launch of three new over-the-counter Refresh Relieva products: Refresh Relieva, Refresh Relieva PF (preservative-free) multidose, and Refresh Relieva for Contacts. This new line of artificial tear formulations available in preserved, preservative-free multidose, and a form
- Allergan to Showcase Late-Stage Data in AMD and Glaucoma at AAO Annual Meetinghttps://modernod.com/news/allergan-to-showcase-late-stage-data-in-amd-and-glaucoma-at-aao-annual-meeting/2476935/Allergan will present new data from investigational abicipar and bimatoprost sustained release (SR) at the annual meeting of the American Academy of Ophthalmology (AAO) to be held in San Francisco, California. The Retina Subspecialty Day (Oc
- Ocular Therapeutix Announces First Patient Dosed in Phase 3 Clinical Trial of Dextenza for the Treatment of Allergic Conjunctivitishttps://modernod.com/news/ocular-therapeutix-announces-first-patient-dosed-in-phase-3-clinical-trial-of-dextenza-for-the-treatment-of-allergic-conjunctivitis/2476914/Ocular Therapeutix announced that it has dosed the first patients in its phase 3 clinical trial of Dextenza for the treatment of symptoms of allergic conjunctivitis. Allergic conjunctivitis refers to inflammation of the conjunctiva of the eye caused by an allergic reaction–generally from airborne
- Haag-Streit Announces the Launch of the Ellex Eye Prime in UKhttps://modernod.com/news/haag-streit-uk-announces-the-launch-of-the-ellex-eye-prime/2476912/Haag-Streit UK (HS-UK) has announced the launch of the Eye Prime diagnostic ultrasound system in the UK. The Eye Prime is the next-generation ultrasound solution from Ellex. It features the industry’s first and only “six-ring phased annular array technology,” delivering crisp, high-de
- Compulink Launches E-Commerce Solution for its All-in-One Optometry EHR at Vision Expo Westhttps://modernod.com/news/compulink-launches-e-commerce-solution-for-its-all-in-one-optometry-ehr-at-vision-expo-west/2476895/Compulink Healthcare Solutions will officially unveil its MyEyeStore e-commerce solution at Vision Expo West from September 19-21, 2019 in Las Vegas. MyEyeStore allows eye care practices to offer their patients the ability to order contact lenses and other recommended products directly fro
- Aerie Pharmaceuticals Submits Prior Approval Supplement to FDA to Allow Production of Rocklatan in its Athlone Ireland Facilityhttps://modernod.com/news/aerie-pharmaceuticals-submits-prior-approval-supplement-to-fda-to-allow-production-of-rocklatan-in-its-athlone-ireland-facility/2476897/Aerie Pharmaceuticals announced the submission of a prior approval supplement (PAS) to the FDA to permit production of Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for sale in the United States in Aerie’s new manufacturing plant in Athlone, Ireland. “Along with t